Literature DB >> 10949913

Transfer factors: identification of conserved sequences in transfer factor molecules.

C H Kirkpatrick1.   

Abstract

BACKGROUND: Transfer factors are small proteins that "transfer" the ability to express cell-mediated immunity from immune donors to non-immune recipients. We developed a process for purifying specific transfer factors to apparent homogeneity. This allowed us to separate individual transfer factors from mixtures containing several transfer factors and to demonstrate the antigen-specificity of transfer factors. Transfer factors have been shown to be an effective means for correction of deficient cellular immunity in patients with opportunistic infections, such as candidiasis or recurrent Herpes simplex and to provide prophylactic immunity against varicella-zoster in patients with acute leukemia.
MATERIALS AND METHODS: Transfer factors of bovine and murine origin were purified by affinity chromatography and high performance liquid chromatography. Cyanogen bromide digests were sequenced. The properties of an apparently conserved sequence on expression of delayed-type hypersensitivity by transfer factor recipients were assessed.
RESULTS: A novel amino acid sequence, LLYAQDL/VEDN, was identified in each of seven transfer factor preparations. These peptides would not transfer expression of delayed-type hypersensitivity to recipients, which indicates that they are not sufficient for expression of the specificity or immunological properties of native transfer factors. However, administration of the peptides to recipients of native transfer factors blocked expression of delayed-type hypersensitivity by the recipients. The peptides were not immunosuppressive.
CONCLUSIONS: These findings suggest that the peptides may represent the portion of transfer factors that binds to the "target cells" for transfer factors. Identification of these cells will be helpful in defining the mechanisms of action of transfer factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10949913      PMCID: PMC1949950     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  10 in total

Review 1.  Measurement of cellular immunity in human coccidioidomycosis.

Authors:  Neil M Ampel
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

2.  Serum Derived Transfer Factor Stimulates the Innate Immune System to Improve Survival Traits in High Risk Pathogen Scenarios.

Authors:  Bridget V Willeford; Trudy Shapiro-Dunlap; Kenneth O Willeford
Journal:  Drug Dev Res       Date:  2017-06-22       Impact factor: 4.360

3.  CD8+ T cells produce a dialyzable antigen-specific activator of dendritic cells.

Authors:  Ian A Myles; Ming Zhao; Glenn Nardone; Lisa R Olano; Jensen D Reckhow; Danial Saleem; Timothy J Break; Michail S Lionakis; Timothy G Myers; Paul J Gardina; Charles H Kirkpatrick; Steven M Holland; Sandip K Datta
Journal:  J Leukoc Biol       Date:  2016-08-11       Impact factor: 4.962

4.  Preparation and properties of the specific anti-influenza virus transfer factor.

Authors:  Chongbi Li; Lihua Huang; Yanping Wang; Xiangle Li; Shaowei Liang; Yingna Zheng
Journal:  Head Face Med       Date:  2010-09-13       Impact factor: 2.151

5.  Clinical Features, Non-Infectious Manifestations and Survival Analysis of 161 Children with Primary Immunodeficiency in Mexico: A Single Center Experience Over two Decades.

Authors:  Saul Oswaldo Lugo Reyes; Guadalupe Ramirez-Vazquez; Alonso Cruz Hernández; Edgar A Medina-Torres; Ana Belen Ramirez-Lopez; Corín España-Cabrera; Citlali A Hernandez-Lopez; Marco A Yamazaki-Nakashimada; Francisco J Espinosa-Rosales; Sara E Espinosa-Padilla; Chiharu Murata
Journal:  J Clin Immunol       Date:  2015-12-28       Impact factor: 8.317

6.  Antiviral mode of action of bovine dialyzable leukocyte extract against human immunodeficiency virus type 1 infection.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Jose I Badillo-Almaraz; Cristina Rodriguez-Padilla
Journal:  BMC Res Notes       Date:  2011-11-01

7.  Effect of Dialyzable Leukocyte Extract on chronic cervicitis in patients with HPV infection.

Authors:  M P Acosta-Rios; E Sauer-Ramírez; L J Castro-Muñoz; M García-Solís; C Gómez-García; R Ocadiz-Delgado; A Martinez-Martinez; V Sánchez-Monroy; C Pérez-De la Mora; B Correa-Meza; D G Perez-Ishiwara
Journal:  J Med Life       Date:  2017 Oct-Dec

8.  Histopathology of murine toxoplasmosis under treatment with dialyzable leukocyte extract.

Authors:  Beatriz Eugenia Fuentes-Castro; Juan Gerardo Reyes-García; María Teresa Valenzuela-Vargas; Federico Martínez-Gómez
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-11       Impact factor: 2.743

9.  Preparation, characterization, and determination of immunological activities of transfer factor specific to human sperm antigen.

Authors:  Jianwei Zhou; Cui Kong; Zhaohong Yuan; Junmin Luo; Rui Ma; Jiang Yu; Jinghe Cao
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

10.  Physicochemical Characteristics of Transferon™ Batches.

Authors:  Emilio Medina-Rivero; Luis Vallejo-Castillo; Said Vázquez-Leyva; Gilberto Pérez-Sánchez; Liliana Favari; Marco Velasco-Velázquez; Sergio Estrada-Parra; Lenin Pavón; Sonia Mayra Pérez-Tapia
Journal:  Biomed Res Int       Date:  2016-07-20       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.